Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448525 · ClinicalTrials.gov registry record · Phase 4
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
A Phase 4 study of Hypotrichosis, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT01448525 is a Phase 4 study of Hypotrichosis that has completed, run by Allergan. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01448525, a Phase 4 study of Hypotrichosis, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.
Conditions Studied
Interventions
- DRUG bimatoprost ophthalmic solution 0.03%
- DRUG bimatoprost vehicle solution
Study Locations (1)
Florida
- - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448525
The ClinicalTrials.gov registry entry for NCT01448525 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypotrichosis appearing as the primary indexed condition, and to 2 interventions - of which bimatoprost ophthalmic solution 0.03% is the first listed.
NCT01448525 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01448525 about?
NCT01448525 is a clinical study titled "Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence". The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.
What is the current status of trial NCT01448525?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2011-10. Estimated completion is 2012-04.
What conditions does trial NCT01448525 study?
This clinical trial studies the following conditions: Hypotrichosis.
What interventions are being tested in trial NCT01448525?
The interventions under investigation include: bimatoprost ophthalmic solution 0.03% (DRUG), bimatoprost vehicle solution (DRUG).
Who is sponsoring clinical trial NCT01448525?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01448525 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotrichosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.